EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtOpen Access · CC BY 4.0

Metformin for Treating Gestational Diabetes: What Have We Learned During the Last Two Decades? A Systematic Review

Angeliki Gerede, Ekaterini Domali iD, Christos Chatzakis iD, Chrysoula Margioula-Siarkou iD, Stamatios Petousis iD, Sofoklis Stavros, Konstantinos Nikolettos, Evanthia Gouveri, Sotirios Sotiriou iD, Panagiotis Tsikouras, Konstantinos Dinas iD, Nikolaos Nikolettos und 3 weitere

Life · 20.01.2025 · 15 (1) · 130

DOI: 10.3390/life15010130 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Life, online erschienen am 20.01.2025. Verfasst von Angeliki Gerede und 14 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Maternal-Fetal-Medicine, Department of Obstetrics and Gynecology, Medical School, Democritus University of Thrake, 67100 Komotini, Greece. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There has been accumulating evidence over the past two decades that metformin can be an effective treatment for gestational diabetes mellitus (GDM) in women whose diet and exercise fail to attain optimal glycemic control. The objective of this review was to comprehensively analyze all studies investigating the effectiveness of metformin compared to insulin and other drugs utilized for the treatment of GDM. After a comprehensive literature review based on PRISMA 2020, 35 studies were included after a selection process utilizing predetermined inclusion and exclusion criteria. A variety of short-term maternal and neonatal outcomes were assessed. Metformin is a highly efficient medication for attaining optimal control of blood sugar levels in women with GDM, resulting in a significant reduction in the amount of weight gained during pregnancy. Regarding additional maternal outcomes, such as pregnancy-induced hypertension and cesarean deliveries, some studies demonstrate a link between metformin and a reduced occurrence of both conditions. In contrast, others do not find an association. Regarding short-term neonatal outcomes, metformin does not exhibit any changes in gestational age at delivery. In contrast, metformin demonstrated substantial decreases in the likelihood of greater gestational birth weight and neonatal hospitalization when compared to other drugs. When compared primarily to insulin, metformin decreases the probability of several short-term outcomes related to pregnancy and newborns. Additional data are necessary for extended follow-up studies, including patients with GDM treated with metformin.

Schlagwörter

Stichwörter der Autor:innen

gestational diabetes mellitusgestational weight gainglycemic controlmetformin

Autor:innen und Institutionen

  • Unit of Maternal-Fetal-Medicine, Department of Obstetrics and Gynecology, Medical School, Democritus University of Thrake, 67100 Komotini, Greece.
  • First Department of Obstetrics and Gynecology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
  • Second Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
  • Third Department of Obstetrics and Gynecology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
  • Diabetes Centre, Second Department of Internal Medicine, University Hospital of Alexandroupolis, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
  • Department of Embryology, Faculty of Medicine, School of Health Sciences, University of Thessaly, 41334 Larissa, Greece.

ORCID-Profile: Ekaterini Domali, Christos Chatzakis, Chrysoula Margioula-Siarkou, Stamatios Petousis, Sotirios Sotiriou, Konstantinos Dinas, Nikolaos Papanas, Dimitrios G Goulis, Alexandros Sotiriadis

Zitieren

APA

Gerede, A., Domali, E., Chatzakis, C., Margioula-Siarkou, C., Petousis, S., Stavros, S., Nikolettos, K., Gouveri, E., Sotiriou, S., Tsikouras, P., Dinas, K., Nikolettos, N., Papanas, N., Goulis, D. G., & Sotiriadis, A. (2025). Metformin for Treating Gestational Diabetes: What Have We Learned During the Last Two Decades? A Systematic Review. Life, 15(1), 130. https://doi.org/10.3390/life15010130

Vancouver

Gerede A, Domali E, Chatzakis C, Margioula-Siarkou C, Petousis S, Stavros S, et al. Metformin for Treating Gestational Diabetes: What Have We Learned During the Last Two Decades? A Systematic Review. Life. 2025;15(1):130. doi:10.3390/life15010130

BibTeX
@article{Gerede2025,
  author = {Gerede, Angeliki and Domali, Ekaterini and Chatzakis, Christos and Margioula-Siarkou, Chrysoula and Petousis, Stamatios and Stavros, Sofoklis and Nikolettos, Konstantinos and Gouveri, Evanthia and Sotiriou, Sotirios and Tsikouras, Panagiotis and Dinas, Konstantinos and Nikolettos, Nikolaos and Papanas, Nikolaos and Goulis, Dimitrios G and Sotiriadis, Alexandros},
  title = {Metformin for Treating Gestational Diabetes: What Have We Learned During the Last Two Decades? A Systematic Review},
  journal = {Life},
  year = {2025},
  volume = {15},
  number = {1},
  pages = {130},
  doi = {10.3390/life15010130}
}
Kostenlos starten →